Zobrazeno 1 - 10 of 3 993 pro vyhledávání: '"Toro D"'
4
Akademický článek
Alterations of the IKZF1-IKZF2 tandem in immune cells of schizophrenia patients regulate associated phenotypes.
Autor: Ballasch I; Departament de Biomedicina, Facultat de Medicina, Institut de Neurociències, Universitat de Barcelona, 08036, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036, Barcelona, Spain.; Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), 28031, Madrid, Spain., López-Molina L; Departament de Biomedicina, Facultat de Medicina, Institut de Neurociències, Universitat de Barcelona, 08036, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036, Barcelona, Spain.; Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), 28031, Madrid, Spain., Galán-Ganga M; Departament de Biomedicina, Facultat de Medicina, Institut de Neurociències, Universitat de Barcelona, 08036, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036, Barcelona, Spain.; Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), 28031, Madrid, Spain., Sancho-Balsells A; Departament de Biomedicina, Facultat de Medicina, Institut de Neurociències, Universitat de Barcelona, 08036, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036, Barcelona, Spain.; Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), 28031, Madrid, Spain., Rodríguez-Navarro I; Departament de Biomedicina, Facultat de Medicina, Institut de Neurociències, Universitat de Barcelona, 08036, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036, Barcelona, Spain.; Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), 28031, Madrid, Spain., Borràs-Pernas S; Departament de Biomedicina, Facultat de Medicina, Institut de Neurociències, Universitat de Barcelona, 08036, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036, Barcelona, Spain.; Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), 28031, Madrid, Spain., Rabadan MA; ZeClinics SL. and ZeNeuroid SL., Barcelona, Spain., Chen W; Departament de Biomedicina, Facultat de Medicina, Institut de Neurociències, Universitat de Barcelona, 08036, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036, Barcelona, Spain.; Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), 28031, Madrid, Spain., Pastó-Pellicer C; Departament de Biomedicina, Facultat de Medicina, Institut de Neurociències, Universitat de Barcelona, 08036, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036, Barcelona, Spain.; Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), 28031, Madrid, Spain., Flotta F; Departament de Biomedicina, Facultat de Medicina, Institut de Neurociències, Universitat de Barcelona, 08036, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036, Barcelona, Spain.; Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), 28031, Madrid, Spain., Maoyu W; Departament de Biomedicina, Facultat de Medicina, Institut de Neurociències, Universitat de Barcelona, 08036, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036, Barcelona, Spain.; Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), 28031, Madrid, Spain., Fernández-Irigoyen J; Proteomics Platform, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra UPNA, IdiSNA, 31008, Pamplona, Spain., Santamaría E; Proteomics Platform, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra UPNA, IdiSNA, 31008, Pamplona, Spain., Aguilar R; ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Catalonia, Spain., Dobaño C; ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Catalonia, Spain.; CIBER Enfermedades Infecciosas (CIBERINFEC), Barcelona, Catalonia, Spain., Egri N; Servei d'Immunologia, Hospital Clinic Barcelona (HCB) - CDB, Fundació Clínic de Recerca Biomèdica - IDIBAPS, Barcelona, Spain., Hernandez C; Parc Sanitari Sant Joan de Déu, CIBERSAM, Barcelona, Spain., Alfonso M; Parc Sanitari Sant Joan de Déu, CIBERSAM, Barcelona, Spain., Juan M; Departament de Biomedicina, Facultat de Medicina, Institut de Neurociències, Universitat de Barcelona, 08036, Barcelona, Spain.; Servei d'Immunologia, Hospital Clinic Barcelona (HCB) - CDB, Fundació Clínic de Recerca Biomèdica - IDIBAPS, Barcelona, Spain.; Plataforma d'Immunoteràpia HSJD-HCB, Barcelona, Spain., Alberch J; Departament de Biomedicina, Facultat de Medicina, Institut de Neurociències, Universitat de Barcelona, 08036, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036, Barcelona, Spain.; Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), 28031, Madrid, Spain.; Production and Validation Centre of Advanced Therapies (Creatio), Faculty of Medicine and Health Science, University of Barcelona, 08036, Barcelona, Spain., Del Toro D; Departament de Biomedicina, Facultat de Medicina, Institut de Neurociències, Universitat de Barcelona, 08036, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036, Barcelona, Spain.; Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), 28031, Madrid, Spain., Arranz B; Parc Sanitari Sant Joan de Déu, CIBERSAM, Barcelona, Spain., Canals JM; Departament de Biomedicina, Facultat de Medicina, Institut de Neurociències, Universitat de Barcelona, 08036, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036, Barcelona, Spain.; Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), 28031, Madrid, Spain.; Production and Validation Centre of Advanced Therapies (Creatio), Faculty of Medicine and Health Science, University of Barcelona, 08036, Barcelona, Spain., Giralt A; Departament de Biomedicina, Facultat de Medicina, Institut de Neurociències, Universitat de Barcelona, 08036, Barcelona, Spain. albertgiralt@ub.edu.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036, Barcelona, Spain. albertgiralt@ub.edu.; Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), 28031, Madrid, Spain. albertgiralt@ub.edu.; Production and Validation Centre of Advanced Therapies (Creatio), Faculty of Medicine and Health Science, University of Barcelona, 08036, Barcelona, Spain. albertgiralt@ub.edu.
Publikováno v: Journal of neuroinflammation [J Neuroinflammation] 2024 Dec 18; Vol. 21 (1), pp. 326. Date of Electronic Publication: 2024 Dec 18.
Zobrazit plný text záznamu
5
Akademický článek
Expansion of the neocortex and protection from neurodegeneration by in vivo transient reprogramming.
Autor: Shen YR; Department of Molecules-Signaling-Development, Max-Planck Institute for Biological Intelligence, 82152 Martinsried, Germany., Zaballa S; Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Institute of Neurosciences, IDIBAPS, University of Barcelona, 08036 Barcelona, Spain; CIBERNED, 08036 Barcelona, Spain., Bech X; Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Institute of Neurosciences, IDIBAPS, University of Barcelona, 08036 Barcelona, Spain; CIBERNED, 08036 Barcelona, Spain., Sancho-Balsells A; Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Institute of Neurosciences, IDIBAPS, University of Barcelona, 08036 Barcelona, Spain; CIBERNED, 08036 Barcelona, Spain., Rodríguez-Navarro I; Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Institute of Neurosciences, IDIBAPS, University of Barcelona, 08036 Barcelona, Spain; CIBERNED, 08036 Barcelona, Spain., Cifuentes-Díaz C; Inserm UMR-S 1270, Sorbonne Université, Science and Engineering Faculty, and Institut du Fer a Moulin, 75005 Paris, France., Seyit-Bremer G; Department of Molecules-Signaling-Development, Max-Planck Institute for Biological Intelligence, 82152 Martinsried, Germany., Chun SH; Department of Molecules-Signaling-Development, Max-Planck Institute for Biological Intelligence, 82152 Martinsried, Germany., Straub T; Bioinformatics Core, Biomedical Center, Faculty of Medicine, Lugwig-Maximilians University (LMU), 82152 Martinsried, Germany., Abante J; Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Institute of Neurosciences, IDIBAPS, University of Barcelona, 08036 Barcelona, Spain; Laboratory of Stem Cells and Regenerative Medicine, University of Barcelona, 08036 Barcelona, Spain; Creatio, Production and Validation Center of Advanced Therapies, Faculty of Medicine and Health Sciences, University of Barcelona, 08036 Barcelona, Spain; Department of Mathematics & Computer Science, University of Barcelona, Barcelona, Spain., Merino-Valverde I; Cambridge Institute of Science, Altos Labs, Granta Park, Cambridge CB21 6GP, UK., Richart L; Cambridge Institute of Science, Altos Labs, Granta Park, Cambridge CB21 6GP, UK., Gupta V; Cambridge Institute of Science, Altos Labs, Granta Park, Cambridge CB21 6GP, UK., Li HY; Department of Molecules-Signaling-Development, Max-Planck Institute for Biological Intelligence, 82152 Martinsried, Germany; Institute of Precision Medicine, College of Medicine, National Sun Yat-Sen University, Kaohsiung, Taiwan., Ballasch I; Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Institute of Neurosciences, IDIBAPS, University of Barcelona, 08036 Barcelona, Spain; CIBERNED, 08036 Barcelona, Spain., Alcázar N; Vall d'Hebron Institute of Oncology (VHIO), 08035 Barcelona, Spain; Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology (BIST), Barcelona 08028, Spain., Alberch J; Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Institute of Neurosciences, IDIBAPS, University of Barcelona, 08036 Barcelona, Spain; CIBERNED, 08036 Barcelona, Spain; Creatio, Production and Validation Center of Advanced Therapies, Faculty of Medicine and Health Sciences, University of Barcelona, 08036 Barcelona, Spain., Canals JM; Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Institute of Neurosciences, IDIBAPS, University of Barcelona, 08036 Barcelona, Spain; Laboratory of Stem Cells and Regenerative Medicine, University of Barcelona, 08036 Barcelona, Spain; Creatio, Production and Validation Center of Advanced Therapies, Faculty of Medicine and Health Sciences, University of Barcelona, 08036 Barcelona, Spain., Abad M; Cambridge Institute of Science, Altos Labs, Granta Park, Cambridge CB21 6GP, UK; Vall d'Hebron Institute of Oncology (VHIO), 08035 Barcelona, Spain., Serrano M; Cambridge Institute of Science, Altos Labs, Granta Park, Cambridge CB21 6GP, UK; Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology (BIST), Barcelona 08028, Spain., Klein R; Department of Molecules-Signaling-Development, Max-Planck Institute for Biological Intelligence, 82152 Martinsried, Germany. Electronic address: ruediger.klein@bi.mpg.de., Giralt A; Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Institute of Neurosciences, IDIBAPS, University of Barcelona, 08036 Barcelona, Spain; CIBERNED, 08036 Barcelona, Spain; Creatio, Production and Validation Center of Advanced Therapies, Faculty of Medicine and Health Sciences, University of Barcelona, 08036 Barcelona, Spain. Electronic address: albertgiralt@ub.edu., Del Toro D; Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Institute of Neurosciences, IDIBAPS, University of Barcelona, 08036 Barcelona, Spain; CIBERNED, 08036 Barcelona, Spain; Creatio, Production and Validation Center of Advanced Therapies, Faculty of Medicine and Health Sciences, University of Barcelona, 08036 Barcelona, Spain. Electronic address: danieldeltoro@ub.edu.
Publikováno v: Cell stem cell [Cell Stem Cell] 2024 Dec 05; Vol. 31 (12), pp. 1741-1759.e8. Date of Electronic Publication: 2024 Oct 18.
Zobrazit plný text záznamu
6
Akademický článek
m 6 A modification of mutant huntingtin RNA promotes the biogenesis of pathogenic huntingtin transcripts.
Autor: Pupak A; Departament de Biomedicina, Facultat de Medicina, Institut de Neurosciències, Universitat de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain., Rodríguez-Navarro I; Departament de Biomedicina, Facultat de Medicina, Institut de Neurosciències, Universitat de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain., Sathasivam K; Department of Neurodegenerative Disease, Huntington's Disease Centre and UK Dementia Research Institute at UCL, Queen Square Institute of Neurology, UCL, London, WC1N 3BG, UK., Singh A; Department for Molecular Biology and Genetics, Aarhus University, Aarhus C, Denmark.; Department of Biomedicine, Aarhus University, Aarhus C, Denmark., Essmann A; Departament de Biomedicina, Facultat de Medicina, Institut de Neurosciències, Universitat de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain., Del Toro D; Departament de Biomedicina, Facultat de Medicina, Institut de Neurosciències, Universitat de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain., Ginés S; Departament de Biomedicina, Facultat de Medicina, Institut de Neurosciències, Universitat de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain., Mouro Pinto R; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.; Department of Neurology, Harvard Medical School, Boston, MA, USA.; Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Bates GP; Department of Neurodegenerative Disease, Huntington's Disease Centre and UK Dementia Research Institute at UCL, Queen Square Institute of Neurology, UCL, London, WC1N 3BG, UK., Vang Ørom UA; Department for Molecular Biology and Genetics, Aarhus University, Aarhus C, Denmark., Martí E; Departament de Biomedicina, Facultat de Medicina, Institut de Neurosciències, Universitat de Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain., Brito V; Departament de Biomedicina, Facultat de Medicina, Institut de Neurosciències, Universitat de Barcelona, Barcelona, Spain. veronica.brito@ub.edu.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. veronica.brito@ub.edu.; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain. veronica.brito@ub.edu.
Publikováno v: EMBO reports [EMBO Rep] 2024 Nov; Vol. 25 (11), pp. 5026-5052. Date of Electronic Publication: 2024 Oct 11.
Zobrazit plný text záznamu
9
Akademický článek
Middle meningeal artery embolization following surgical evacuation of symptomatic chronic subdural hematoma improves outcomes, interim results of a prospective randomized trial.
Autor: Debs LH; Neurosurgery Department, Medical College of Georgia, Augusta, GA, USA. Electronic address: ldebs@augusta.edu., Vale FL; Neurosurgery Department, Medical College of Georgia, Augusta, GA, USA., Walker S; Neurosurgery Department, Medical College of Georgia, Augusta, GA, USA., Toro D; Neurosurgery Department, Medical College of Georgia, Augusta, GA, USA., Mansouri S; Neurosurgery Department, Medical College of Georgia, Augusta, GA, USA., Macomson SD; Neurosurgery Department, Medical College of Georgia, Augusta, GA, USA., Rahimi SY; Neurosurgery Department, Medical College of Georgia, Augusta, GA, USA.
Publikováno v: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia [J Clin Neurosci] 2024 Oct; Vol. 128, pp. 110783. Date of Electronic Publication: 2024 Aug 13.
Zobrazit plný text záznamu
10
Akademický článek
Usage of the Anemia Control Model Is Associated with Reduced Hospitalization Risk in Hemodialysis.
Autor: Garbelli M; Clinical Advanced Analytics, Global Medical Office, Fresenius Medical Care, 26020 Vaiano Cremasco, Italy., Baro Salvador ME; Nephrocare Spain, Fresenius Medical Care, 08013 Barcelona, Spain., Rincon Bello A; Nephrocare Spain, Fresenius Medical Care, 08013 Barcelona, Spain., Samaniego Toro D; Nephrocare Spain, Fresenius Medical Care, 08013 Barcelona, Spain., Bellocchio F; Clinical Advanced Analytics, Global Medical Office, Fresenius Medical Care, 26020 Vaiano Cremasco, Italy., Fumagalli L; Clinical Advanced Analytics, Global Medical Office, Fresenius Medical Care, 26020 Vaiano Cremasco, Italy., Chermisi M; Clinical Advanced Analytics, Global Medical Office, Fresenius Medical Care, 26020 Vaiano Cremasco, Italy., Apel C; Health Economics and Market Access, Fresenius Medical Care, 61352 Bad Homburg, Germany., Petrovic J; Health Economics and Market Access, Fresenius Medical Care, 61352 Bad Homburg, Germany., Kendzia D; Health Economics and Market Access, Fresenius Medical Care, 61352 Bad Homburg, Germany., Ion Titapiccolo J; Clinical Advanced Analytics, Global Medical Office, Fresenius Medical Care, 26020 Vaiano Cremasco, Italy., Yeung J; Clinical Advanced Analytics, Global Medical Office, Fresenius Medical Care, 26020 Vaiano Cremasco, Italy., Barbieri C; Global Digital and Innovation Technology Department, Fresenius Medical Care, 26020 Vaiano Cremasco, Italy., Mari F; Global Digital and Innovation Technology Department, Fresenius Medical Care, 26020 Vaiano Cremasco, Italy., Usvyat L; Clinical Advanced Analytics, Global Medical Office, Fresenius Medical Care, 26020 Vaiano Cremasco, Italy., Larkin J; Clinical Advanced Analytics, Global Medical Office, Fresenius Medical Care, 26020 Vaiano Cremasco, Italy., Stuard S; Clinical and Therapeutic Governance EMEA, Medical Affairs, Global Medical Office, Fresenius Medical Care, 26020 Vaiano Cremasco, Italy., Neri L; Clinical Advanced Analytics, Global Medical Office, Fresenius Medical Care, 26020 Vaiano Cremasco, Italy.
Publikováno v: Biomedicines [Biomedicines] 2024 Sep 28; Vol. 12 (10). Date of Electronic Publication: 2024 Sep 28.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje